# Rein Therapeutics (RNTX) — Earnings

RNTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rntx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.21 |
| EPS estimate | −$0.24 |
| EPS surprise | +12.50% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1420565/000119312525281622/rntx-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 14, 2025 | −$0.24 | −$0.21 | 12.50% | — | — |
| Q2 2025 | Aug 14, 2025 | −$0.22 | −$0.28 | -27.27% | — | — |
| Q1 2025 | May 15, 2025 | −$0.21 | −$0.25 | -19.05% | — | — |
| Q4 2024 | Apr 7, 2025 | −$0.30 | −$1.89 | -530.00% | — | — |
| Q3 2024 | Nov 14, 2024 | −$0.25 | −$0.27 | -10.20% | — | — |
| Q2 2024 | Aug 14, 2024 | −$0.23 | −$0.45 | -99.47% | — | — |
| Q1 2024 | May 15, 2024 | −$0.14 | −$0.86 | -514.29% | — | — |
| Q4 2023 | Apr 15, 2024 | −$0.16 | −$1.54 | -840.75% | — | — |
| Q3 2023 | Oct 13, 2023 | −$0.20 | −$0.40 | -100.00% | — | — |
| Q3 2022 | Nov 1, 2022 | −$1.65 | −$1.40 | 15.15% | — | — |
| Q2 2022 | Aug 15, 2022 | −$1.70 | −$1.80 | -5.88% | — | — |
| Q1 2022 | May 5, 2022 | −$1.53 | −$1.80 | -17.39% | — | — |
| Q4 2021 | Mar 28, 2022 | −$1.60 | −$1.60 | 0.00% | — | — |
| Q3 2021 | Nov 12, 2021 | −$1.40 | −$1.40 | 0.00% | — | — |
| Q2 2021 | Aug 11, 2021 | −$1.47 | −$1.20 | 18.18% | — | — |
| Q1 2021 | May 11, 2021 | −$1.35 | −$1.60 | -18.52% | — | — |
| Q4 2020 | Mar 24, 2021 | −$2.55 | −$2.40 | 5.83% | — | — |
| Q3 2020 | Nov 12, 2020 | −$2.50 | −$2.60 | -4.00% | — | — |
| Q2 2020 | Aug 5, 2020 | −$3.75 | −$2.80 | 25.33% | — | — |
| Q1 2020 | May 11, 2020 | −$4.05 | −$4.80 | -18.52% | — | — |

## Frequently Asked Questions

### When did Rein Therapeutics (RNTX) last report earnings?

Rein Therapeutics last reported on Nov 14, 2025, covering fiscal Q3 2025.

### Did RNTX beat earnings estimates?

Yes. Rein Therapeutics reported EPS of −$0.21 for Q3 2025 against a −$0.24 estimate — a 12.50% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).